global+growth

Wealthy nations reiterated their opposition to a proposal to waive intellectual property rules for COVID-19 drugs.

For years, China has been a primary source of fentanyl trafficked into the United States.

The Lipitor and Viagra maker is embarking on a strategic shift to maintain growth in the world’s second-largest drug market after China slashed prices for off-patent medicines by more than 90% in some instances.

The announcements come as 94 higher-income economies have officially joined the COVAX Facility, a global effort to ensure rapid and equitable access to safe and effective COVID-19 vaccines for the most vulnerable groups across the world.

Can a drug manufacturer declare when a pandemic is over?

Communication from India and South Africa

Investor Presentation Oct 2020

One of the great divides this COVID-19 pandemic has brought to light is the difference between the survival prospects for the rich and the poor.

The disease has killed more than 1.1 million people, including nearly 220,000 in the U.S., which remains the world's worst-hit country despite having less than 5% of the global population.

To efficiently deal with the pandemic and keep everyone safe, we first need to transform the pharmaceutical industry.

As wealthier countries buy up supplies of Western drugmakers’ Covid-19 vaccines that are still in development, China and Russia are offering their fast-tracked shots to poorer nations.

More than 180 countries have committed to participate in the World Health Organization’s (WHO) effort to finance COVID-19 vaccines to be distributed fairly to both rich and poor countries.

The first study on global drug production.

The vaccine will be ready for wide distribution late this year or early next, officials say. That's roughly the same schedule as shots from rivals in the U.S., U.K. and China.

Indonesia Plans to Vaccinate 160 Million People by End of 2021.